Zobrazeno 1 - 10
of 28
pro vyhledávání: '"E, Warry"'
Publikováno v:
Journal of Veterinary Internal Medicine
Background No biomarkers for the early detection of gastrointestinal (GI) toxicosis secondary to antineoplastic treatment are recognized in veterinary medicine. Toceranib causes GI toxicosis in dogs. Hypothesis/Objective To assess if changes in plasm
Autor:
Eric M. Green, Wm Tod Drost, Andrew J. Leffler, Emma E. Warry, Danelle M. Auld, Gregory G. Habing, Eric T. Hostnik
Publikováno v:
Veterinary Radiology & Ultrasound. 59:767-776
Transitional cell carcinoma is the most common cancer of the canine urinary tract. The inconsistent appearance of transitional cell carcinoma in patients introduces error if applying mathematic models for extrapolating total tumor volume from linear
Autor:
Vincent A Wavreille, E. Warry, Kathleen L. Ham, Judith Bertran, M. Martinez, Mary A. McLoughlin, M. Breit
Publikováno v:
Journal of Small Animal Practice. 59:783-787
A 5-year-old pug presented with a soft tissue swelling on the ventral neck and moderate stridor with associated respiratory effort. This patient received hypofractionated radiotherapy for metastatic upper lip mast cell tumour and to the submandibular
Publikováno v:
Journal of Veterinary Internal Medicine
Background Peripheral blood CD34+ hematopoietic cell transplantation (PBHCT) is commonly used to treat human patients with relapsed non-Hodgkin diffuse, large B-cell lymphoma with cure rates approaching 50%. Objective To determine the safety and feas
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
William Tod Drost, Cheryl A. London, Eric M. Green, Sarah B. Rippy, Emma E. Warry, Roberta F. Portela, Juan Peng, Heather L. Gardner, Sandra M. Nguyen, Dennis J. Chew, Eric T. Hostnik
Publikováno v:
BMC Veterinary Research
Background Effective therapies for transitional cell carcinoma (TCC) are limited, with objective response rates to most chemotherapeutic regimens below 20%. The purpose of this study was to investigate the biologic activity of combined toceranib phos
Autor:
Trevor W, Moore, R Timothy, Bentley, Sarah A, Moore, Michele, Provencher, Emma E, Warry, Rebecca, Kohnken, Hock Gan, Heng
Publikováno v:
Veterinary radiologyultrasound : the official journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association. 58(1)
Published information regarding canine vertebral column mast cell tumors (MCTs) is limited. The objectives of this study were to report clinical and advanced imaging findings for a group of dogs with confirmed spinal MCT. Inclusion criteria for this
Pharmacokinetics of Cyclophosphamide after Oral and Intravenous Administration to Dogs with Lymphoma
Publikováno v:
Journal of Veterinary Internal Medicine. 25:903-908
Background: Cyclophosphamide is an alkylating chemotherapeutic drug administered IV or PO. It is currently assumed that exposure to the active metabolite, 4-hydroxycyclophosphamide (4-OHCP), is the same with either route of administration. Objectives
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Megan E. Brown, Christian Argueta, Erkan Baloglu, Hua Chang, Elizabeth M. Schuh, Trinayan Kashyap, Sharon Shacham, Cheryl London, Emma E. Warry, William Senapedis, Joel Ellis
Publikováno v:
Cancer Research. 77:LB-308
Nicotinamide adenine dinucleotide (NAD), an essential metabolite and cofactor of several biological processes (e.g. genomic stability), undergoes significant alterations during malignant transformation. In cancer cells, the high metabolic demands of